SCIREX Appoints Linda Metcalf Sr. VP, Global Clinical Trial Management
SCIREX announced today the appointment of Linda Metcalf to the position of Senior Vice President, Global Clinical Trial Management. In this role, Ms. Metcalf will be responsible for the global strategic, tactical, and operational performance of the Clinical Trials Management Department, and have direct responsibility for the Clinical Quality Management (CQM) group.
(PRWEB) July 28, 2005 -- SCIREX announced today the appointment of Linda
Metcalf to the position of Senior Vice President, Global Clinical Trial
Management. In this role, Ms. Metcalf will be responsible for the global
strategic, tactical, and operational performance of the Clinical Trials
Management Department, and have direct responsibility for the Clinical Quality
Management (CQM) group. Ms. Metcalf will be located at SCIREX’s Horsham, PA,
corporate headquarters.
Linda possesses over twenty years of clinical
drug development experience in pharmaceutical, biotechnology and contract
research organization environments. She has a broad pharmaceutical background in
both Research and Development, and Marketing areas, as well as operations and
business expertise in developing and implementing both strategic and tactical
plans to achieve company and departmental business objectives.
Linda
joins SCIREX from prior positions at both Omnicare Clinical Research, Inc.,
where she served most recently as Senior Vice President, Clinical Operations,
Americas, and Covance, Inc. where she was Clinical Operations Director, with
direct responsibility for organizational alignment of clinical operations and
data management. Prior to her experiences in the CRO Industry, Linda was
employed for over twenty years at G. D. Searle and Company in various roles of
increasing responsibility in the areas of Research and Development and
Clinical/Project Management, with experience in therapeutic areas including
Allergy/inflammation, Asthma, Rheumatoid Arthritis, Dermatitis, and Oncology.
Linda has also had extensive experience in international drug development,
having served in global roles of varying capacity in both pharmaceutical and CRO
environments.
Linda obtained her BS degree in Microbiology from the
University of Michigan and her MS in Cell Biology from Northwestern University.
She has been well published on various topics relating cell biology, and has
been a featured speaker at scientific conferences on these subjects.
About SCIREX
SCIREX Corporation is a leader in the delivery of Phase
I-IV drug development services to the global pharmaceutical and biotechnology
industries. SCIREX’s clinical trial management capabilities include drug
development planning, protocol design, submission services, regulatory affairs
consulting, investigator and patient recruitment, data management, statistics,
medical writing and offers an array of technology solutions including IVRS, EDC
and SIMS(TM) (Study Information Management System). SCIREX's experience
portfolio includes more than 1,000 clinical trials involving well over 130,000
patients, evaluating new treatments for pain and inflammation, neurological and
psychiatric disorders, infectious diseases and gastrointestinal and
cardiovascular indications. SCIREX is a wholly-owned subsidiary of Omnicom
Group, Inc.
For more information contact Blythe Vito, SCIREX Corporate
Marketing at (215) 907-1330 x1054, or visit www.scirex.com.
# # #
Source : http://www.prweb.com/releases/2005/7/prweb265863.htm